INM: InMed Pharmaceuticals Inc. Net earnings per share growth forecast for next year

Symbol and logo of brand inmedpharma.com (INM)

InMed Pharmaceuticals (INM) leads in the biosynthesis of rare cannabinoids via genetic engineering. The company minimizes risks by developing unique preparations for the skin and eyes. Demand for these methods remains high, although sales have not yet commenced. The expected earnings per share growth on the GURU.Markets chart reflects the analyst consensus, where 0.00 represents the latest metric reading.

INM: InMed Pharmaceuticals Inc Expected net earnings per share growth next year 07/04/2022 - 11/09/2026

inmedpharma.com - analytical breakdowns and key metrics (INM)

- price and consensus price forecast:
Price Chart InMed Pharma|INM - Broker Consensus Forecast
- market capitalization information:
Market Value InMed Pharmaceuticals|INM - Real Price to Acquire Entire Company
- company book value details:
Book Value per Share InMed Pharmaceuticals|INM - Total Stockholders' Equity|Market Capitalization to Book Value Ratio inmedpharma.com|INM - Total Business Assets
- company liabilities and liquidity data:
Total Debt to Equity Ratio InMed Pharmaceuticals|INM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity InMed Pharmaceuticals Inc.|INM - Company Aggregate Indebtedness|Debts to Book Capitalization InMed Pharmaceuticals|INM - Company Long-Term Loans and Borrowings|Company Short-Term Debts InMed Pharmaceuticals|Quick Liquidity inmedpharma.com
- earnings and valuation multiples information:
INM - Final Profit|Expected Profit InMed Pharmaceuticals|INM - Price to Earnings Ratio|Forward P/E Multiple InMed Pharmaceuticals|INM - PEG Multiple|EV/EBITDA Multiple InMed Pharmaceuticals|INM - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) InMed Pharmaceuticals|INM - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months inmedpharma.com|INM - Earnings growth in current year|Expected earnings per share growth for next year InMed Pharmaceuticals
- total revenue and sales volume data:
INM - Company Total Sales|Projected Sales Volume InMed Pharma|INM - Price-to-Revenue Coefficient|Forward P/S Multiple InMed Pharmaceuticals
Summary company analytics:InMed Pharma, INM
Brand item of InMed Pharmaceuticals Inc.

The market valuation of InMed Pharmaceuticals (INM) depends directly on the efficiency of rare molecule synthesis and the success of clinical trials in glaucoma therapy. The trend in consensus EPS forecasts for the coming year reflects analysts' average earnings expectations, allowing the gap between fundamental value and price to determine the asset's true growth trajectory, where an upward trend confirms the issuer's investment stability.

Competitor analysis for InMed Pharmaceuticals

Net earnings per share growth forecast for next year Indivior Group|Projected earnings per share growth rate for next year COLL (Collegium Corp)|Net earnings per share growth forecast for next year Cronos Group Inc. (CRON)|Expected earnings per share growth for next year canopygrowth.com CGC|Earnings growth forecast for next year HITI (High Tide)|Aurora Cannabis, Inc. (ACB) - Expected net earnings per share growth next year|Achieve Life Sciences, Inc - Earnings growth forecast for next year|SKYE (Skye Bioscience Inc.) - Projected earnings per share growth rate for next year|ANEB (Anebulo Pharmaceuticals) - Expected earnings per share growth for next year|InterCure - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Nutriband Inc|Nasus Pharma, Ltd. - Net earnings per share change forecast for next year|Earnings growth forecast for next year IGC|MIRA (mirapharmaceuticals.com) - Expected earnings per share trend next year|Earnings growth forecast for next year FLGC (Flora Growth Corp.)|Earnings growth forecast for next year IM Cannabis Corp IMCC|ADIL - Net earnings per share growth forecast for next year|Expected earnings per share trend next year ARTL (Artelo Biosciences)|ensysce.com (ENSC) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Titan Pharmaceuticals, Inc.|GNLN (Greenlane Holdings) - Earnings growth forecast for next year|Earnings growth forecast for next year akandacorp.com|Earnings growth forecast for next year ENVB|Expected earnings per share growth for next year brightgreen.us BGXX|Earnings growth forecast for next year HPCO (Hempacco Co., Inc.)